ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 359

Diminished Health-Related Quality of Life As Measured By the Short Form-10 in Children with Hypophosphatasia

Thomas J. Weber1, Eileen K. Sawyer2, Scott Moseley2 and Priya S. Kishnani1, 1Duke University Medical Center, Durham, NC, 2Alexion Pharmaceuticals, Cheshire, CT

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: bone disease, pediatrics and quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Osteoporosis and Metabolic Bone Disease - Clinical Aspects and Pathogenesis Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Hypophosphatasia is a rare metabolic disease caused by loss-of-function mutation(s) in the gene encoding the tissue non-specific alkaline phosphatase (ALP). In children, low tissue non-specific ALP activity leads to deficient skeletal mineralization and complications that may include poor growth, proximal muscle weakness, pain, and compromised physical function. The impact of these symptoms on health-related quality of life is not known.

Methods: The Short Form-10 (a short version of the Child Health Questionnaire) was administered as part of the internet-based Hypophosphatasia Impact Patient Survey (HIPS) developed to characterize the burden of disease in patients with hypophosphatasia. Outreach from 2009-2011 by patient advocacy groups provided awareness of the survey to patients or caregivers and invited participation. Summary statistics were calculated for the norm-based Physical Health and Psychosocial Summary scores (healthy population mean=50, standard deviation [SD]=10) and for each individual question.

Results: Forty-four children (50% male, 80% via caregiver respondents) participated in the Hypophosphatasia Impact Patient Survey, of which 39 completed the Short Form-10. Mean (SD) age at the time of the survey was 6.8 (4.8) years; age at onset of hypophosphatasia symptoms was 0.9 (1.0) years. The majority of children reported pain (82%, 38/44), including in the joints (61%, 27/44) and bones (52%, 23/44), and muscle weakness (66%, 29/44). Thirty-six percent (16/44) reported fractures. The mean Physical Health score (23.7, 95% confidence interval [CI]: 17.2-30.3, n=39) was >2 SD below normal. The mean Psychosocial Summary score (45.6, 95% CI: 41.9-49.3, n=39) revealed a small decrease relative to population norms. The majority of children reported limitations in high energy activities such as riding a bike or skating (79%, 31/39); basic activities such as bending, lifting, and stooping (64%, 25/39); and school work or activities with friends (62%, 24/39) due to physical health problems. Eighty-two percent (32/39) reported experiencing pain in the past 4 weeks. Behavioral and emotional problems limited school or social activities in 33% (13/39) of children, and behavior was rated by the respondent as “Good” or higher for 90% (35/39) of the children.

Conclusion: As reported by caregivers/patients and consistent with the reported burden of symptoms, hypophosphatasia has a high physical impact on children which reduces their ability to keep up with peers and participate in normal childhood activities, including both high energy and daily living activities, substantially diminishing health-related quality of life. The lower impact of hypophosphatasia on psychosocial health reported herein may reflect higher resilience to disease in children compared with adults, or the influence of parental report. An understanding of the impact of hypophosphatasia on health-related quality of life is important for evaluating future treatment options. Further studies are needed to characterize health-related quality of life longitudinally in these patients.


Disclosure: T. J. Weber, Alexion Pharmaceuticals, Inc., 5; E. K. Sawyer, Alexion Pharmaceuticals, Inc., 3; S. Moseley, Alexion Pharmaceuticals, Inc., 3; P. S. Kishnani, Alexion Pharmaceuticals, Inc., 5,Alexion Pharmaceuticals, Inc., 6.

To cite this abstract in AMA style:

Weber TJ, Sawyer EK, Moseley S, Kishnani PS. Diminished Health-Related Quality of Life As Measured By the Short Form-10 in Children with Hypophosphatasia [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/diminished-health-related-quality-of-life-as-measured-by-the-short-form-10-in-children-with-hypophosphatasia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diminished-health-related-quality-of-life-as-measured-by-the-short-form-10-in-children-with-hypophosphatasia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology